Call us on 1300 794 893

The Experts

Stock of the week

Jun Bei Liu
Friday, November 09, 2018

Bookmark and Share

What is the stock?

CSL is Australia’s leading biotechnology company. It is the global leader in the blood plasma therapies sector and the second-largest supplier of seasonal influenza vaccines, with combined annual sales of more than US$7.5 billion.

How long have you held the stock?

We have held it since June 2017.

To continue reading this article, take a free 21-day trial to the Switzer Report. Click here to sign up.


Published: Friday, November 09, 2018

New on Switzer

blog comments powered by Disqus
Pixel_admin_thumb_300x300 Pixel_admin_thumb_300x300